TrialHuman vaccines & immunotherapeutics2025

A Phase 3 study to assess the safety and immunogenicity of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) co-administered with routine pediatric vaccines in healthy infants in the USA and Puerto Rico.

James D Campbell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.